Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1

Overview of attention for article published in Molecular Cancer, May 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 20,951 followers.

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and... http://t.co/cHKLj2mg3M

LRRK2-IN-1 demonstrates activity vs colorectal & pancreatic cancer through inhibition of doublecortin-like kinase 1 http://t.co/6Q0aLVjSpB

LRRK2-IN-1 demonstrates activity vs colorectal & pancreatic cancer through inhibition of doublecortin-like kinase 1 http://t.co/6Q0aLVjSpB

LRRK2-IN-1 demonstrates activity vs colorectal & pancreatic cancer through inhibition of doublecortin-like kinase 1 http://t.co/6Q0aLVjSpB

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.